BIT Capital’s MBX Biosciences MBX Stock Holding History

BIT Capital’s Portfolio MBX Stock Details MBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,743	Closed	-$235K	–	146
2024 Q4	$235K	Buy	+12,743	New	+$272K	0.02%	94

Other funds holding MBX

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BIT Capital's MBX Position: Q1 2025 in Review

BIT Capital sold out of MBX Biosciences (MBX) in Q1 2025, closing a stake of 12,743 shares — an estimated $235K sold.

BIT Capital first reported a position in MBX in Q4 2024 and held it in 1 quarter. The position peaked at $235K in Q4 2024. 79 funds tracked by Wall St. Rank hold MBX as of Q1 2025.

BIT Capital reported no remaining MBX Biosciences position as of Q1 2025 after selling out during the quarter.
BIT Capital sold 12,743 MBX Biosciences shares in Q1 2025, an estimated $235K.
BIT Capital first reported a position in MBX Biosciences in Q4 2024 and held it in 1 quarter.
BIT Capital's MBX Biosciences position peaked at $235K in Q4 2024.
79 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2025.

Based on BIT Capital's 13F filing for Q1 2025, filed 9 May 2025.